Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

PREFERENCE Exploring Extended Field-of-view PET for precision medicine

Coordinator
Stichting Amsterdam Umc, Netherlands
Runs
1 October 2026 to 30 September 2030
Status
Running
EU funding
€4.8m
Total cost
—
Partners
21 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101307478

What the project is doing

In the project's own words, from its summary on CORDIS.

Recently, long axial field of view (LAFOV) PET/CT systems have been introduced in the market (more than 15 in EU) and an increasing number of systems are becoming available in Europe. These systems have an ultra-large anatomical coverage, allowing dynamic imaging covering all major organs. With a sensitivity up to 20x higher than current state of the art PET/CT, molecular imaging can now be performed with ultra-low radiation doses, allowing more repeat imaging, either for multi-radiotracer studies for comprehensive disease characterization or longitudinal studies/follow up diagnostics.

This is of particular interest with the advent of novel targeted drugs and cell therapies for which there is an unmet need to achieve better in vivo phenotyping and/or characterization of disease for a more precise diagnosis as well as better understanding of drug delivery and targeting to predict treatment response. Our proposed training network, PREFERENCE, will train 15 doctoral candidates (DCs) to fully exploit the benefits of large axial FOV PET/CT imaging.

The network involves 13 PET centres, all with LAFOV PET/CT, a leading global manufacturer of LAFOV PET/CT systems and SMEs developing imaging software. Our individual research projects will develop new LAFOV methodologies to improve image quality and diagnosis, to enable studying human whole body disease connectomes, to allow for non-invasive full kinetic analysis, to facilitate low dose multi-tracer and/or multi-repeat LAFOV PET/CT imaging.

Several DCs will use LAFOV PET/CT in clinical research to gain new insights and knowledge of pathophysiology and precision medicine in clinical research and patient care, increased understanding of pathophysiological processes and diagnosis for various clinical applications by using multi-tracer as well as dynamic imaging procedures. DCs will also experience a cutting-edge doctoral training programme including data analysis, artificial intelligence, innovation and entrepreneurship.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Amsterdam UmcAmsterdamNetherlandsCoordinator
Medizinische Universitaet WienWienAustriaParticipant
Universitaet BernBernSwitzerlandParticipant
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Ruprecht-Karls-Universitaet HeidelbergHeidelbergGermanyAssociatedpartner
Siemens Healthineers AGForchheimGermanyParticipant
Aarhus UniversitetAarhus CDenmarkAssociatedpartner
Aarhus UniversitetshospitalAarhusDenmarkParticipant
Kobenhavns UniversitetKobenhavnDenmarkAssociatedpartner
Region HovedstadenHillerodDenmarkParticipant
Turun YliopistoTurkuFinlandParticipant
Universite De BrestBrestFranceParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Rijksuniversiteit GroningenGroningenNetherlandsAssociatedpartner
Stichting VuAmsterdamNetherlandsAssociatedpartner
Antaros Medical ABMolndalSwedenParticipant
Collective Minds Radiology ABDanderydSwedenAssociatedpartner
Uppsala UniversitetUppsalaSwedenAssociatedpartner
King's College LondonLondonUnited KingdomParticipant
The University of EdinburghEdinburghUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI